Catalyst Wire Dossier Catalyst Wire Dossier

XIENCE PRIME SV

everolimus-eluting coronary stent · Abbott Medical Devices
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for XIENCE PRIME SV, covering 2019-07-22 to 2019-07-22. Get the full timeline:

Most recent: Clinical Trial Update: XIENCE PRIME SV Everolimus Eluting Coronary Stent Japan Post Marketing Surveillance (XIENCE PRIME SV Japan PMS)

See pricing